Earnings Reported After The Bell Mar.10

(RTTNews) - Here is a quick summary of the earnings reported after the bell on Mar.10.

Finisar Corporation (FNSR)

Q3 net income was $12.08 million or $0.11 per share vs. $1.68 million or $0.02 per share a year ago.

Non-GAAP net income was $26.6 million or $0.25 per share.

Revenue was $309.2 million vs. 306.28 million a year ago.

Analysts expected the company to report net income of $0.22 per share on revenues of $311.97 million for the period.

Q4 Outlook

Revenues to be in the range of $307 million to $327 million.

Non-GAAP earnings per share in the range of $0.22 to $0.28.

Analysts expect the company to report net income of $0.21 per share on revenues of $314.66 million for the period.

***

Dicerna Pharmaceuticals, Inc. (DRNA)

Q4 net loss attributable to common stockholders was $15.6 million or $0.76 per share compared to net loss attributable to common stockholders of $14.6 million or $0.82 per share a year ago.

***

Zogenix, Inc. (ZGNX)

Q4 net loss was $8.8 million, or $0.36 per share, compared with net loss of $20.5 million, or $1.09 per share a year ago.

Total revenue for the fourth quarter was $6.1 million vs. $9.9 million in the same quarter last year.

***

Surgery Partners, Inc. (SGRY)

Q4 net income was $36.09 million or $0.35 per share vs. net loss of $36.77 million or $1.69 per share a year ago.

Total revenues for the fourth quarter of 2015 increased 46.5% to $263.3 million from $179.7 million for the fourth quarter of 2014.

Analysts expected the company to report net income of $0.19 per share on revenues of $246.7 million for the period.

FY Outlook

Revenues to be in the range of $1.10 billion to $1.14 billion.

Analysts expect the company to report revenues of $1.05 billion for the period.

***

Kratos Defense & Security Solutions, Inc. (KTOS)

Q4 net loss was $4 million or $0.07 per share vs. net loss of $2.2 million or $0.04 per share a year ago.

Adjusted income from continuing operations was $1.2 million or $0.02 per share vs. $3.8 million or $0.06 per share a year ago.

Revenue was $177.5 million vs. $192.1 million a year ago.

***

STRATA Skin Sciences, Inc. (SSKN)

Q4 net loss was $0.6 million or $0.06 per share vs. net loss of $6.4 million or $1.09 per share a year ago.

Revenues for the fourth quarter were $9.5 million compared with $0.4 million a year ago.

***

China Lodging Group, Limited (HTHT)

Q4 net income attributable to China Lodging Group, Limited was RMB70.8 million or $10.9 million compared to RMB46.8 million in the fourth quarter of last year.

Q4 earnings per ADS were RMB1.10 or $0.17.

Adjusted net income attributable to China Lodging Group, Limited for the fourth quarter was RMB84.7 million or $13.1 million.

Adjusted earnings per ADS were RMB1.32 or US$0.20.

Total revenues for the fourth quarter were RMB1,593.3 million or $246.0 million, representing a 16.1% year-over-year increase.

***

NV5 Global, Inc. (NVEE)

Q4 net income was $2.7 million, or $0.33 per share, up from $1.4 million, or $0.25 per share in the fourth quarter of last5 year.

Adjusted EPS for the fourth quarter was $0.41 vs. $0.30 a year ago.

Total Revenues for the fourth quarter of 2015 were $42.6 million, a 47% increase from the fourth quarter of 2014.

Analysts expected the company to report net income of $0.35 per share on revenues of $45.05 million for the period.

FY Outlook

Revenue to be in the range from $220 million to $230 million.

GAAP EPS to range from $1.40 to $1.54.

Adjusted EPS to range from $1.67 to $1.81.

Analysts expect the company to report net income of $1.36 per share on revenues of $194.65 million for the period.

***

Manitex International, Inc. (MNTX)

Q4 net loss was $5.5 million or $0.34 per share vs. net income of $472000 a year ago.

Net revenues increased 50.1% year-over-year to $93.5 million compared to $62.3 million.

***

Cumulus Media Inc. (CMLS)

Q4 net loss was $4.6 million or $0.02 per share vs. net income of $3.36 million or $0.02 per share a year ago.

Net revenue was $308.8 million vs. $329.25 million a year ago.

***

Cara Therapeutics, Inc. (CARA)

Q4 net loss was $9.5 million, or $0.35 per share compared to net loss of $4.2 million, or $0.18 per share a year ago.

Revenue was nil vs. collaborative revenue of $399,000 a year ago.

***

ARI Network Services, Inc. (ARIS)

Q2 net income was $448,000, or $0.03 per share compared with $260,000 or $0.02 per share last year.

Revenues were $11.8 million for the second quarter compared with $10.1 million for the same period last year.

Analysts expected the company to report net income of $0.03 per share on revenues of $11.79 million for the period.

***

21Vianet Group, Inc. (VNET)

Q4 net loss was RMB112.9 million or $17.4 million compared with net loss of RMB155.5 million a year ago.

Loss per ADS was RMB1.44 or $0.22.

Adjusted net loss was RMB29.1 million or $4.5 million compared with profit of RMB7.1 million in the comparative period last year.

Net revenues for the fourth quarter increased by 15.2% to RMB983.4 million or $151.8 million from RMB853.9 million in the comparative period last year.

***

Immune Design (IMDZ)

Q4 net loss was $12.1 million or $0.60 per share compared to $13.1 million or $0.78 per share a year ago.

Revenue for the fourth quarter was $1.1 million vs. $1.8 million a year ago.

***

BioDelivery Sciences International, Inc. (BDSI)

Q4 net income was $10.2 million, or $0.19 per share, compared to net loss of $17.6 million, or $0.36 per share a year ago.

Net revenue was $32.2 million vs. $2.5 million a year ago.

***

Verifone (PAY)

Q1 net income attributable to VeriFone Systems, Inc. stockholders was $23.5 million or $0.21 per share vs. $13.8 million or $0.12 per share a year ago.

Non-GAAP EPS was $0.48 vs. $0.44 a year ago.

Net revenue was $514 million vs. $486 million a year ago.

Analysts expected the company to report net income of $0.46 per share on revenues of $501.22 million for the period.

Q2 Outlook

Non-GAAP net revenues of $530 million.

Non-GAAP net income per share to be in the range of $0.51 to $0.52.

Analysts expect the company to report net income of $0.51 per share on revenues of $515.25 million for the period.

FY Outlook

Non-GAAP net revenues to be in the range of $2.150 billion to $2.170 billion.

Non-GAAP net income per share to be in the range of $2.21 to $2.24.

Analysts expect the company to report net income of $2.16 per share on revenues of $2.10 billion for the period.

***

Ulta Beauty (ULTA)

Q4 net income increased to $107.8 million or $1.69 per share compared to $87.3 million or $1.35 per share in the fourth quarter of last year.

Net sales increased 21.1% to $1,268.3 million from $1,047.6 million a year ago.

Analysts expected the company to report net income of $1.54 per share on revenues of $1.23 billion for the period.

Q1 Outlook

Net sales to be in the range of $1.016 billion to $1.033 billion.

EPS is estimated to be in the range of $1.25 to $1.30.

Analysts expect the company to report net income of $1.22 per share on revenues of $1.01 billion for the period.

***

OncoMed Pharmaceuticals, Inc. (OMED)

Q4 net loss was $24.8 million or $0.82 per share compared to $15.1 million or $0.50 per share a year ago.

Non-GAAP net income was $45.3 million or $1.50 per share compared to loss of $18.9 million or $0.63 per share for the same period last year.

Revenues decreased to $6.8 million compared to $8.5 million a year ago.

***

Violin Memory Inc. (VMEM)

Q4 GAAP net loss was $25.5 million, or $0.26 per share compared to net loss of $46.8 million, or $0.50 per share a year ago.

Non-GAAP net loss was $19.4 million, or $0.20 per share, compared to loss of $18.1 million, or $0.19 per share a year ago.

Revenue was $10.9 million compared to $20.5 million a year ago.

***

Zumiez Inc. (ZUMZ)

Q4 net income decreased 24.9% to $13.1 million, or $0.50 per share, from $17.5 million, or $0.60 per share a year ago.

Total net sales for the fourth quarter decreased 6.2% to $242.4 million from $258.6 million a year ago.

Analysts expected the company to report net income of $0.50 per share on revenues of $241.1 million for the period.

Q1 Outlook

Net sales are projected to be in the range of $172 million to $175 million and net loss per share to be in the range of $0.07 to -$0.11.

Analysts expect the company to report net loss of $0.01 per share on revenues of $177.8 million for the period.

***

Energous Corporation (WATT)

Q4 GAAP net loss was $8.9 million, or $0.61 per share vs. net loss of $9.02 million or $0.89 per share a year ago.

***

Limoneira Company (LMNR)

Q1 net loss applicable to common stock was $4.1 million or $0.29 per share compared to net loss of $1.6 million or $0.11 per share a year ago.

Revenue was $25.0 million, compared to $28.0 million a year ago.

FY Outlook

EPS to be in the range of $0.28 to $0.33, compared to the previous range of $0.25 to $0.29.

Non-GAAP earnings per share are expected to be in the range of $0.33 to $0.38, compared to previous estimates of $0.30 to $0.34.

***

Eldorado Resorts, Inc. (ERI)

Q4 net loss was $110.15 million or $2.33 per share vs. net loss of $10.94 million or $0.24 per share a year ago.

Net operating revenues were $186.16 million vs. $164.1 million a year ago.

***

Dynamic Materials Corporation (BOOM)

Q4 loss from continuing operations was $16.04 million or $1.15 per share vs. loss of $3.58 million or $0.32 per share a year ago.

Q4 non-GAAP loss from continuing operations was $3.1 million, or $0.22 per share vs. income from continuing operations of $1.4 million, or $0.10 per share a year ago.

Fourth quarter sales were $41.9 million vs. $52.0 million in the 2014 fourth quarter.

***

QAD Inc. (QADA)

Q4 GAAP net income was $4.1 million, or $0.22 per Class A share and $0.18 per Class B share, compared with $6.9 million, or $0.42 per Class A share and $0.36 per Class B share.

Non-GAAP net income was $5.9 million, or $0.31 per Class A share and $0.26 per Class B share, compared with $8.5 million, or $0.51 per Class A share and $0.45 per Class B share.

Revenue was $69.26 million vs. $79.56 million a year ago.

Analysts expected the company to report net income of $0.18 per share on revenues of $70.51 million for the period.

Q1 Outlook

Total revenue to be in the range of $64 million to $66 million.

GAAP loss per share to be in the range of $0.08 to $0.06 per Class A share and $0.07 to $0.05 per Class B share.

Non-GAAP earnings per share to be in the range of $0.00 to $0.02 per Class A and B shares.

Analysts expect the company to report net income of $0.14 per share on revenues of $69.63 million for the period.

FY Outlook

Total revenue to be in the range of $279 million to $285 million

GAAP earnings per share to be in the range of $0.30 to $0.38 per Class A share and $0.24 to $0.32 per Class B share.

Non-GAAP earnings per share to be in the range of $0.65 to $0.73 per Class A share and $0.53 to $0.61 per Class B share.

Analysts expect the company to report net income of $0.78 per share on revenues of $286.57 million for the period.

***

Sysorex Global (SYRX)

Q4 net loss was $3.96 million or $0.16 per share vs. net loss of $1.82 million or $0.09 per share a year ago.

Non-GAAP net loss was $1.13 million or $0.04 per share vs. loss of $1.04 million or $0.05 per share a year ago.

Revenue was $20.26 million vs. $15.2 million a year ago.

***

Neonode Inc. (NEON)

Q4 net loss was $2.6 million, or $0.06 per share, compared to net loss of $3.1 million, or $0.08 per share, for the comparable quarter last year.

Net revenue for the fourth quarter was $3.0 million, an increase of 71% compared to the comparable quarter last year.

***

Evoke Pharma, Inc. (EVOK)

Q4 net loss was $2.6 million, or $0.37 per share, compared to net loss of $2.9 million, or $0.48 per share a year ago.

***

Athersys, Inc. (ATHX)

Q4 net income was $3.6 million or $0.04 per share compared to net loss of $6.6 million or $0.08 per share a year ago.

Revenues were $10.6 million compared to $0.2 million a year ago.

***

Threshold Pharmaceuticals, Inc. (THLD)

Q4 net income was $69.7 million or $0.86 per share compared to net loss of $6.0 million or $0.12 per share a year ago.

Revenue was $65.87 million vs. $3.68 million a year ago.

***

Diversified Restaurant Holdings, Inc. (SAUC)

Q4 net loss was $9.6 million compared to a net loss of $1.4 million last year.

Adjusted net loss was $0.4 million vs. $0.2 million a year ago.

Revenue increased 39.7% to $49.1 million compared to $35.1 million a year ago.

FY Outlook

Revenue to be in the range of $194.0 million to $200.0 million.

***

Alliance HealthCare Services, Inc. (AIQ)

Q4 net loss was $0.3 million or $0.02 per share compared to net income of $1.9 million or $0.17 per share a year ago.

Adjusted EPS was $0.31.

Revenue for the fourth quarter increased to $124.3 million, compared to $109.6 million a year ago.

FY Outlook

Revenue to be in the range of $505 million to $535 million.

***

Veracyte, Inc. (VCYT)

Q4 net loss was $8.0 million, or $0.29 per share, compared to net loss of $8.1 million, or $0.36 per share a year ago.

Revenue was $14.0 million compared to $12.2 million a year ago.

FY Outlook

Revenue to be in the range of $59 million to $63 million.

***

SciClone Pharmaceuticals, Inc. (SCLN)

Q4 net income was $12.5 million, or $0.24 per share compared to $3.5 million, or $0.07 per share a year ago.

Non-GAAP net income was $15.5 million, or $0.30 per share compared with $15.4 million, or $0.29 per share for the same period of the prior year.

Revenues were $42.9 million, compared to $41.4 million a year ago.

***

Medifast, Inc. (MED)

Q4 income from continuing operations was $3.9 million, or $0.33 per share vs. $2.6 million, or $0.21 per share a year ago.

Net revenue from continuing operations decreased 2% to $61.3 million from $62.3 million a year ago.

Analysts expected the company to report net income of $0.35 per share on revenues of $62.98 million for the period.

Q1 Outlook

Net revenue from continuing operations to be in the range of $68.0 million to $71.0 million and adjusted earnings per share from continuing operations in the range of $0.30 to $0.33.

Analysts expect the company to report net income of $0.44 per share on revenues of $72.98 million for the period.

FY Outlook

Revenue from continuing operations to be in the range of $273.0 million to $280.0 million and earnings per share from continuing operations in the range of $1.73 to $1.78 per share.

Analysts expect the company to report net income of $1.85 per share on revenues of $282.08 million for the period.

***

Five Prime Therapeutics, Inc. (FPRX)

Q4 net income was $296.1 million, or $10.63 per share, compared to net loss of $11.8 million, or $0.55 per share a year ago.

Collaboration revenue for the fourth quarter increased by $358.7 million to $363.3 million from $4.6 million a year ago.

Analysts expected the company to report net income of $9.67 per share on revenues of $354.16 million for the period.

***

Autobytel Inc. (ABTL)

Q4 net income increased 24% to $1.4 million or $0.10 per share, compared to $1.1 million or $0.11 per share in the year-ago quarter.

Non-GAAP income increased to $4.4 million or $0.33 per share compared to $2.5 million or $0.23 per share a year ago.

Total revenues in the fourth quarter increased 40% to $36.4 million compared to $26.0 million in the year-ago quarter.

Analysts expected the company to report net income of $0.24 per share on revenues of $36.21 million for the period.

FY Outlook

Revenue to range between $151 million and $155 million.

Non-GAAP EPS to range between $1.39 and $1.43.

Analysts expect the company to report net income of $1.41 per share on revenues of $151.31 million for the period.

***

FTD Companies, Inc. (FTD)

Q4 consolidated net loss was $82.2 million or $2.90 per share compared to net income of $3.9 million or $0.19 per share a year ago.

Adjusted net income for the fourth quarter was $15.6 million, compared to $10.4 million for the same period of the prior year.

Consolidated revenues were $297.7 million compared to $157.5 million a year ago.

FY Outlook

Consolidated revenues to be in the range of flat to down 4%.

***

Exa Corporation (EXA)

Q4 GAAP net loss was $1.3 million or $0.09 per share compared to net loss of $1.1 million or $0.08 per share for the comparable period last year.

Non-GAAP net loss was $0.9 million, or $0.06 per share compared to loss of $0.6 million, or $0.04 per share a year ago.

Total revenue for the fourth quarter was $18.3 million, an increase of 8% compared to $16.9 million a year ago.

Q1 Outlook

Total revenue is expected to be in the range of $16.5 million to $17.0 million.

GAAP net loss is expected to be in the range of $1.9 million to $1.4 million.

Non-GAAP net loss is expected to be in the range of $1.5 million to $1.0 million.

FY Outlook

Total revenue is expected to be in the range of $72.5 million to $75.0 million.

GAAP net loss is expected to be in the range of $5.4 million to $3.6 million.

Non-GAAP net loss is expected to be in the range of $3.1 million to $1.3 million.

***

Crossroads Systems, Inc. (CRDS)

Q1 net loss available to common stockholders was $189,000 or $0.1 per share, compared to net loss of $2.4 million or $0.15per share in the same quarter a year ago.

Revenue was $2.0 million, compared to $2.2 million in the same quarter a year ago.

***

Pfenex Inc. (PFNX)

Q4 net loss was $8.67 million or $0.37 per share vs net loss of $3.57 million or $0.18 per share a year ago.

Total Revenue increased by 62%, to $3.3 million compared to $2.0 million a year ago.

***

Bojangles', Inc. (BOJA)

Q4 net Income decreased slightly to $7.8 million or $0.21 per share from $7.9 million or $0.21 per share a year ago.

Adjusted net income increased to $8.2 million or $0.22 per share from $7.7 million or $0.21 per share a year ago.

Total revenues increased 9.6% to $128.8 million from $117.4 million in the prior year fiscal quarter.

Analysts expected the company to report net income of $0.19 per share on revenues of $127.66 million for the period.

FY Outlook

Total revenues to be in the range of $533.0 million to $543.0 million.

Non-GAAP EPS to be in the range of $0.86 to $0.90.

Analysts expect the company to report net income of $0.88 per share on revenues of $540.15 million for the period.

***

El Pollo Loco Holdings, Inc. (LOCO)

Q4 net income was $5.4 million, or $0.14 per share, compared to $4.6 million, or $0.12 per share in the prior year.

Adjusted net income increased 8.7% to $6.0 million, or $0.15 per share, compared to $5.5 million, or $0.14 per share.

Total revenue was $86.3 million compared to $90.0 million a year ago.

Analysts expected the company to report net income of $0.13 per share on revenues of $88.03 million for the period.

***

Cerulean Pharma Inc. (CERU)

Q4 net loss attributable to common stockholders was $10.7 million, compared to net loss of $7.5 million a year ago.

***

Sunrun (RUN)

Q4 net loss attributable to common stockholders was $15.0 million or $0.15 per share compared to net loss of $26.7 million a year ago.

Total revenue grew to $99.6 million from $60.1 million a year ago.

***

KMG (KMG)

Q2 net income was $3.98 million or $0.33 per share vs. $5.49 million or $0.47 per share a year ago.

Adjusted earnings per share was $0.40 vs. $0.30 per share a year ago.

Net sales were $70.86 million vs. $79.76 million a year ago.

Analysts expected the company to report net income of $0.35 per share on revenues of $75.1 million for the period.

FY Outlook

Net sales are forecast to be approximately $300 million.

Analysts expect the company to report revenues of $302.9 million for the period.

***

Galena Biopharma, Inc. (GALE)

Q loss from continuing operations was $10.8 million or $0.07 per share vs. loss from continuing operations of $6.3 million or $0.05 per share a year ago.

***

Comtech Telecommunications Corp. (CMTL)

Q2 GAAP net income was $2.5 million, or $0.15 per share compared to $7.6 million, or $0.46 per share a year ago.

Non-GAAP EPS was $0.25.

Analysts expect the company to report net income of $0.26 per share for the period.

Net sales were $70.3 million compared to $81.8 million a year ago.

***

Trovagene, Inc. (TROV)

Q4 net loss was $7.4 million, or $0.26 per share compared to net loss of $4.7 million, or $0.25 per share a year ago.

***

Arrhythmia Research Technology, Inc. (HRT)

Q4 net loss was $387000 or $0.14 per share vs. net income of $32000 or $0.01 per share a year ago.

Net sales were $4.75 million vs. $5.74 million a year ago.

***

Ooma, Inc. (OOMA)

Q4 GAAP net loss was $3.2 million, or $0.19 per share, compared to net loss of $4.1 million, or $1.66 per share a year ago.

Non-GAAP net loss was $1.6 million, or $0.10 per share, compared to loss of $3.0 million, or $1.21 per share a year ago.

Total revenue was $24.3 million, up 16% year-over-year.

Q1 Outlook

Total revenue to be between $23.5 million and $24.3 million.

Non-GAAP net loss per share to be in the range of $0.09 to $0.11.

FY Outlook

Total revenue to be in the range of $102 million to $107 million.

Non-GAAP net loss per share to be in the range of $0.23 to $0.31.

***

Franco-Nevada Corporation (FNV)

Q4 net loss was $31.4 million, or $0.20 per share vs. net income of $1.6 million, or $0.01 per share a year ago.

Adjusted net income was $23.7 million, or $0.15 per share vs. $31.6 million or $0.20 per share a year ago.

Revenue was $121.3 million vs. $123.0 million a year ago.

Analysts expected the company to report net income of $0.13 per share on revenues of $116.83 million for the period.

***

Gastar Exploration Inc. (GST)

Q4 net loss attributable to Gastar's common stockholders was $161.1 million, or $2.07 per share vs. net income of $26.67 million or $0.34 per share a year ago.

Adjusted net loss attributable to common stockholders was $12.6 million, or $0.16 per share.

Revenues were $22.61 million vs. $61.45 million a year ago.

***

FutureFuel Corp. (FF)

Q4 net income decreased to $29.6 million, or $0.68 per share, from $30.1 million, or $0.69 per share a year ago.

Revenues were $33.9 million, down 61.6% from $88.5 million a year ago.

Analysts expected the company to report net income of $0.28 per share on revenues of $33.87 million for the period.

***

Willdan Group, Inc. (WLDN)

Q4 net income was $0.4 million, or $0.05 per share compared to $2.0 million, or $0.26 per share a year ago.

Total contract revenue for the fourth quarter increased 4.3% to $31.5 million, as compared to $30.2 million a year ago.

FY Outlook

Total contract revenue to be in the range of $170 million - $185 million.

***

Genco Shipping & Trading Limited (GNK)

Q4 net loss attributable to Genco Shipping & Trading Limited was $49.5 million, or $0.69 per share vs. net loss of $164.0 million, or $2.72 per share a year ago.

Revenue was $34.95 million vs. $55.7 million a year ago.

***

GeoPark Limited (GPRK)

Q4 net loss was $157.6 million vs. net loss of $29.1 million a year ago.

Revenue was $45.4 million vs. $80.8 million a year ago.

***

Xunlei Limited (XNET)

Q4 net loss from continuing operations was $4.6 million or 0.0595 per share compared with net income of $7.21 million or $0.1125 per share a year ago.

Non-GAAP net loss from continuing operations was $2.2 million or $0.024 per ADS.

Total revenues were $35.1 million, down 1.1% on a year-over-year from $35.5 million.

Q1 Outlook

Total revenues to be between $35 million and $38 million.

***

Weis Markets, Inc. (WMK)

Q4 net income increased to $16.6 million or $0.61 per share from $13.7 million or $0.51 per share a year ago.

Net sales were $734.06 million vs. $713.79 million a year ago.

***